Souhaitez-vous accéder aux communiqués récents ?

Noted pharmaceutical industry executive Frederick Beddingfield, MD, PhD, has joined the Neurodon Board of Directors, bringing years of industry leadership.

Claimable Honored in Fast Company’s 2025 World Changing Ideas Awards. Recognition comes as Claimable expands its impact with support for GLP-1 appeals.

Kailera Therapeutics today announced the appointments of Adam Koppel and Christopher Hite to its Board of Directors.

DirectMeds acquires Autumn DNA to launch the first DNA-based supplement system in telehealth—unlocking personalized care beyond prescriptions.

Sagapixel reports “GLP-1” has overtaken “Ozempic” in search volume, signaling a major shift in patient awareness and provider marketing and SEO strategy.

CHIPPENHAM, England, May 22, 2025 (GLOBE NEWSWIRE) -- CheqUp, one of the UK’s leading providers of GLP-1 based weight loss services, and WeightWatchers, the global leader in science-backed weight...

- Announced preclinical data demonstrating the bioequivalence of RT-114, a bispecific GLP-1/GLP-2 receptor agonist (PG-102), delivered orally via the RaniPill® capsule, to subcutaneous administration...

VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) -- Pramana Pharmaceuticals, a late-stage preclinical biopharmaceutical company developing a transformative small molecule platform...

Company Announces Strategic Realignment to Focus on Core Programs and Extend Cash Runway Icovamenib progressing toward the next phase of clinical development in insulin deficient type 2 diabetes...

The U.S. Phase 2 trial aims to evaluate efficacy and safety of CX11 in doses up to 200 mg and different titration schemesThe trial is expected to enroll 250 patients to receive treatment over 36 weeks...